HuMax-EGFR-2F8
HuMax-EGFR-2F8 Uses, Dosage, Side Effects, Food Interaction and all others data.
HuMax-EGFR-2F8 is a fully human IgG1 monoclonal antibody designed to bind with selectivity to the epidermal growth factor receptor (EGFR). HuMax-EGFR-2F8 has been investigated for the treatment of Squamous Cell Cancer and Head and Neck Cancer.
| Trade Name | HuMax-EGFR-2F8 |
| Generic | Zalutumumab |
| Zalutumumab Other Names | Zalutumumab |
| Type | |
| Formula | C6512H10074N1734O2032S46 |
| Weight | 146641.0546 Da |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here HuMax-EGFR-2F8
